Form 8-K - Current report:
SEC Accession No. 0001193125-25-031973
Filing Date
2025-02-21
Accepted
2025-02-21 16:01:18
Documents
14
Period of Report
2025-02-14
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d894992d8k.htm   iXBRL 8-K 26549
  Complete submission text file 0001193125-25-031973.txt   196141

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cnta-20250214.xsd EX-101.SCH 3285
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnta-20250214_def.xml EX-101.DEF 14707
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnta-20250214_lab.xml EX-101.LAB 24578
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnta-20250214_pre.xml EX-101.PRE 15665
16 EXTRACTED XBRL INSTANCE DOCUMENT d894992d8k_htm.xml XML 6259
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40445 | Film No.: 25651589
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)